EE91 Economic Evaluation of Durvalumab for the Treatment of Patients With Stage III Unresectable Locally Advanced Non-Small Cell Lung Cancer Whose Disease Has Not Progressed After Platinum-Based Chemoradiation Therapy

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.343
https://www.valueinhealthjournal.com/article/S1098-3015(22)02547-5/fulltext
Title : EE91 Economic Evaluation of Durvalumab for the Treatment of Patients With Stage III Unresectable Locally Advanced Non-Small Cell Lung Cancer Whose Disease Has Not Progressed After Platinum-Based Chemoradiation Therapy
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02547-5&doi=10.1016/j.jval.2022.09.343
First page :
Section Title :
Open access? : No
Section Order : 12157
Categories :
Tags :
Regions :
ViH Article Tags :